Explore the latest in oncology, including recent guidelines and advances in the screening, diagnosis, and treatment of breast and lung cancer.
This cross-sectional study examines cigarette smoking prevalence and behaviors (continuing or quitting smoking) among cancer survivors and compares them between survivors of smoking-related cancers and non–smoking-related cancers.
This cohort study evaluates the association of a comprehensive skin toxicity program for patients with cancer with adherence to prophylaxis guidelines for the prevention of epidermal growth factor receptor inhibitor–associated cutaneous toxic effects at the Dana-Farber Cancer Institute.
This cohort study uses data from the National Cancer Database from 2007 to 2016 to investigate the association between breast cancer stage at diagnosis and patient insurance status, age, and race/ethnicity before and after the expansion of Medicaid.
This cohort study assesses whether TP53 clonal variants can be detected in Papanicolaou test samples from women later diagnosed with high-grade serous epithelial ovarian cancer (HGS-EOC).
This case-control study examines the association of polygenic risk scores with changes in breast cancer risk in women who are carriers of pathogenic variants in breast cancer susceptibility genes.
This case report describes a 63-year-old man with acute myeloid leukemia who presented with a red, dome-shaped papule under the right lower eyelid.
This population-based cohort study examines associations of voriconazole and other antifungal medications with risk of keratinocyte carcinomas in recipients of lung transplants.
This systematic review and meta-analysis examines whether biologic treatment of inflammatory bowel disease, rheumatoid arthritis, or psoriasis is associated with increased risk of melanoma compared with conventional systemic therapy.
This systematic review and meta-analysis quantifies the risk of recurrence and death associated with minimally invasive vs open radical hysterectomy for early-stage cervical cancer in observational studies optimized to control for confounding.
This Teachable Moment emphasizes the importance of using tumor marker testing only in the most appropriate clinical context to avoid patient anxiety and delayed diagnosis.
A healthy man in his 60s presents with a blurred vision in his left eye and findings were suggestive of lymphoid tumor and a choroidal lymphoid process. What would you do next?
This nonrandomized phase 2 study assesses the feasibility and safety of durvalumab treatment in adults with advanced solid tumors and HIV-1 infection.
This systematic review and meta-analysis evaluates the association of immune checkpoint inhibitor treatment with overall response rate, disease control rate, overall survival, and progression-free survival in patients with microsatellite instability-high cancers.
A 75-year old woman with a history of follicular lymphoma and breast cancer presents with gradual vision loss and confusion; magnetic resonance imaging reveals hyperintensity in the left occipital and temporal lobes. What is your diagnosis?
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: